CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
2020· article· en· New England Journal of Medicine· Medicine
afffund
1,856
citations
Every work in the frame. Each row carries the routes that admitted it, because a frame that forgets how it found something cannot be audited.
Direct labels are sparse and unvalidated. Missing labels are unknown.